Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 964

1.

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor.

Holtan SG, Hoeschen AL, Cao Q, Arora M, Bachanova V, Brunstein CG, Miller JS, Rashidi A, Slungaard A, Ustun C, Vercellotti GM, Warlick ED, Betts BC, El Jurdi N, He F, Chen C, Gandhi I, Wagner JE, Blazar BR, Jacobson PA, Shabaneh A, Wang J, Panoskaltsis-Mortari A, MacMillan ML, Weisdorf DJ.

Blood Adv. 2020 Apr 14;4(7):1284-1295. doi: 10.1182/bloodadvances.2019001259.

PMID:
32236525
2.

Recent progress in and challenges in cellular therapy using NK cells for hematological malignancies.

Tanaka J, Miller JS.

Blood Rev. 2020 Mar 20:100678. doi: 10.1016/j.blre.2020.100678. [Epub ahead of print] Review.

PMID:
32229065
3.

Heparin-Induced Thrombocytopenia in Patients Undergoing Valvular and Aortic Surgery: A Modern Assessment of Risk.

Zapata D, Binongo J, Lasanajak Y, Wei J, Leshnower BG, Chen EP, Miller JS, Lattouf OM, Guyton RA, Halkos ME, Keeling B.

Innovations (Phila). 2020 Mar 26:1556984520909799. doi: 10.1177/1556984520909799. [Epub ahead of print]

PMID:
32216511
4.

Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML.

Bultitude WP, Schellekens J, Szydlo RM, Anthias C, Cooley SA, Miller JS, Weisdorf DJ, Shaw BE, Roberts CH, Garcia-Sepulveda CA, Lee J, Pearce RM, Wilson MC, Potter MN, Byrne JL, Russell NH, MacKinnon S, Bloor AJ, Patel A, McQuaker IG, Malladi R, Tholouli E, Orchard K, Potter VT, Madrigal JA, Mayor NP, Marsh SGE.

Bone Marrow Transplant. 2020 Mar 13. doi: 10.1038/s41409-020-0858-9. [Epub ahead of print]

PMID:
32203258
5.

A Lifespan Approach to Patient-Reported Outcomes and Quality of Life for People on the Autism Spectrum.

Graham Holmes L, Zampella CJ, Clements C, McCleery JP, Maddox BB, Parish-Morris J, Udhnani MD, Schultz RT, Miller JS.

Autism Res. 2020 Mar 10. doi: 10.1002/aur.2275. [Epub ahead of print]

PMID:
32154664
6.

KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.

Weisdorf D, Cooley S, Wang T, Trachtenberg E, Vierra-Green C, Spellman S, Sees JA, Spahn A, Vogel J, Fehniger TA, Woolfrey AE, Devine SM, Ross M, Waller EK, Sobecks RM, McGuirk J, Oran B, Farag SS, Shore T, Van Besien K, Marsh SGE, Guethlein LA, Parham P, Miller JS.

Blood Adv. 2020 Feb 25;4(4):740-754. doi: 10.1182/bloodadvances.2019001053.

7.

Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function.

Sarhan D, Wang J, Sunil Arvindam U, Hallstrom C, Verneris MR, Grzywacz B, Warlick E, Blazar BR, Miller JS.

JCI Insight. 2020 Mar 12;5(5). pii: 130155. doi: 10.1172/jci.insight.130155.

8.

Priorities in coronary artery bypass grafting: Is midterm survival more dependent on completeness of revascularization or multiple arterial grafts?

Rosenblum JM, Binongo J, Wei J, Liu Y, Leshnower BG, Chen EP, Miller JS, Macheers SK, Lattouf OM, Guyton RA, Thourani VH, Halkos ME, Keeling WB.

J Thorac Cardiovasc Surg. 2019 Dec 20. pii: S0022-5223(19)39882-4. doi: 10.1016/j.jtcvs.2019.11.125. [Epub ahead of print]

PMID:
32005574
9.

The Effects of Neonatal Abstinence Syndrome on Language Delay from Birth to 10 Years.

Miller JS, Anderson JG, Erwin PC, Davis SK, Lindley LC.

J Pediatr Nurs. 2020 Mar - Apr;51:67-74. doi: 10.1016/j.pedn.2019.12.011. Epub 2020 Jan 7.

PMID:
31923742
10.

Pluripotent stem cell-derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity.

Zhu H, Blum RH, Bjordahl R, Gaidarova S, Rogers P, Lee TT, Abujarour R, Bonello GB, Wu J, Tsai PF, Miller JS, Walcheck B, Valamehr B, Kaufman DS.

Blood. 2020 Feb 6;135(6):399-410. doi: 10.1182/blood.2019000621.

PMID:
31856277
11.

Disturbed flow disrupts the blood-brain barrier in a 3D bifurcation model.

Bouhrira N, DeOre BJ, Sazer DW, Chiaradia Z, Miller JS, Galie PA.

Biofabrication. 2020 Feb 27;12(2):025020. doi: 10.1088/1758-5090/ab5898.

PMID:
31739299
12.

Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation.

Newell LF, DeFor TE, Cutler C, Verneris MR, Blazar BR, Miller JS, Antin JH, Howard A, Wu J, MacMillan ML, Panoskaltsis-Mortari A, Weisdorf DJ, Holtan SG.

Biol Blood Marrow Transplant. 2020 Mar;26(3):606-611. doi: 10.1016/j.bbmt.2019.11.006. Epub 2019 Nov 10.

PMID:
31715306
13.

A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.

Pomeroy EJ, Hunzeker JT, Kluesner MG, Lahr WS, Smeester BA, Crosby MR, Lonetree CL, Yamamoto K, Bendzick L, Miller JS, Geller MA, Walcheck B, Felices M, Webber BR, Starr TK, Moriarity BS.

Mol Ther. 2020 Jan 8;28(1):52-63. doi: 10.1016/j.ymthe.2019.10.009. Epub 2019 Oct 15.

PMID:
31704085
14.

Harnessing Natural Killer Cell Antitumor Immunity: From the Bench to Bedside.

Woan KV, Miller JS.

Cancer Immunol Res. 2019 Nov;7(11):1742-1747. doi: 10.1158/2326-6066.CIR-19-0404. Review.

PMID:
31676567
15.

"I wouldn't know where to start": Perspectives from clinicians, agency leaders, and autistic adults on improving community mental health services for autistic adults.

Maddox BB, Crabbe S, Beidas RS, Brookman-Frazee L, Cannuscio CC, Miller JS, Nicolaidis C, Mandell DS.

Autism. 2019 Nov 1:1362361319882227. doi: 10.1177/1362361319882227. [Epub ahead of print]

PMID:
31674198
16.

Solid-State 13 C NMR Evidence for Long Multicenter Intradimer Bonding in Zwitterion-like Structures.

Elliott AB, Versfeld G, Halling MD, Miller JS, Harper JK.

Chemistry. 2020 Jan 2;26(1):230-236. doi: 10.1002/chem.201903099. Epub 2019 Nov 21.

PMID:
31613014
17.

Accuracy of Autism Screening in a Large Pediatric Network.

Guthrie W, Wallis K, Bennett A, Brooks E, Dudley J, Gerdes M, Pandey J, Levy SE, Schultz RT, Miller JS.

Pediatrics. 2019 Oct;144(4). pii: e20183963. doi: 10.1542/peds.2018-3963.

PMID:
31562252
18.

Human NK Cell Development: One Road or Many?

Cichocki F, Grzywacz B, Miller JS.

Front Immunol. 2019 Aug 29;10:2078. doi: 10.3389/fimmu.2019.02078. eCollection 2019. Review.

19.

Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD.

Koehn BH, Saha A, McDonald-Hyman C, Loschi M, Thangavelu G, Ma L, Zaiken M, Dysthe J, Krepps W, Panthera J, Hippen K, Jameson SC, Miller JS, Cooper MA, Farady CJ, Iwawaki T, Ting JP, Serody JS, Murphy WJ, Hill GR, Murray PJ, Bronte V, Munn DH, Zeiser R, Blazar BR.

Blood. 2019 Nov 7;134(19):1670-1682. doi: 10.1182/blood.2019001950.

PMID:
31533918
20.

The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples.

Rashidi A, Luo X, Cooley S, Anasetti C, Waller EK, Brunstein CG, Cichocki F, Weisdorf DJ, Miller JS.

Blood Adv. 2019 Aug 27;3(16):2465-2469. doi: 10.1182/bloodadvances.2019000298. No abstract available.

21.

Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia.

Yun HD, Schirm DK, Felices M, Miller JS, Eckfeldt CE.

Blood Adv. 2019 Aug 27;3(16):2448-2452. doi: 10.1182/bloodadvances.2019000064. No abstract available.

22.

Factors Influencing the Use of Cognitive-Behavioral Therapy with Autistic Adults: A Survey of Community Mental Health Clinicians.

Maddox BB, Crabbe SR, Fishman JM, Beidas RS, Brookman-Frazee L, Miller JS, Nicolaidis C, Mandell DS.

J Autism Dev Disord. 2019 Nov;49(11):4421-4428. doi: 10.1007/s10803-019-04156-0.

PMID:
31385175
23.

Viewpoint: Metalloids-An Electronic Band Structure Perspective.

Miller JS.

Chemistry. 2019 Aug 27;25(48):11177-11179. doi: 10.1002/chem.201903167. Epub 2019 Aug 2.

PMID:
31373421
24.

Ten simple rules for giving an effective academic job talk.

Sura SA, Smith LL, Ambrose MR, Amorim CEG, Beichman AC, Gomez ACR, Juhn M, Kandlikar GS, Miller JS, Mooney J, Mummah RO, Lohmueller KE, Lloyd-Smith JO.

PLoS Comput Biol. 2019 Jul 25;15(7):e1007163. doi: 10.1371/journal.pcbi.1007163. eCollection 2019 Jul. No abstract available.

25.

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia.

Cooley S, He F, Bachanova V, Vercellotti GM, DeFor TE, Curtsinger JM, Robertson P, Grzywacz B, Conlon KC, Waldmann TA, McKenna DH, Blazar BR, Weisdorf DJ, Miller JS.

Blood Adv. 2019 Jul 9;3(13):1970-1980. doi: 10.1182/bloodadvances.2018028332.

26.

Feedback loops in the major evolutionary transition to eusociality: the status and potential of theoretical approaches.

Miller JS, Reeve HK.

Curr Opin Insect Sci. 2019 Aug;34:85-90. doi: 10.1016/j.cois.2019.04.008. Epub 2019 May 8. Review.

PMID:
31247424
27.

Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming.

Merino A, Zhang B, Dougherty P, Luo X, Wang J, Blazar BR, Miller JS, Cichocki F.

J Clin Invest. 2019 Jun 18;130:3770-3785. doi: 10.1172/JCI125916.

28.

Autism spectrum disorder and neurodevelopmental delays in children with giant omphalocele.

Danzer E, Hoffman C, Miller JS, D'Agostino JA, Schindewolf EM, Gerdes M, Bernbaum J, Adams SE, Rintoul NE, Herkert LM, Taylor L, Schreiber J, Peranteau WH, Flake AW, Adzick NS, Hedrick HL.

J Pediatr Surg. 2019 Sep;54(9):1771-1777. doi: 10.1016/j.jpedsurg.2019.05.017. Epub 2019 May 28.

PMID:
31196668
29.

What's in a name? A preliminary event-related potential study of response to name in preschool children with and without autism spectrum disorder.

Thomas RP, Wang LAL, Guthrie W, Cola M, McCleery JP, Pandey J, Schultz RT, Miller JS.

PLoS One. 2019 May 7;14(5):e0216051. doi: 10.1371/journal.pone.0216051. eCollection 2019.

30.

Multivascular networks and functional intravascular topologies within biocompatible hydrogels.

Grigoryan B, Paulsen SJ, Corbett DC, Sazer DW, Fortin CL, Zaita AJ, Greenfield PT, Calafat NJ, Gounley JP, Ta AH, Johansson F, Randles A, Rosenkrantz JE, Louis-Rosenberg JD, Galie PA, Stevens KR, Miller JS.

Science. 2019 May 3;364(6439):458-464. doi: 10.1126/science.aav9750.

PMID:
31048486
31.

Colonization, Baker's law, and the evolution of gynodioecy in Hawaii: implications from a study of Lycium carolinianum.

Miller JS, Blank CM, Levin RA.

Am J Bot. 2019 May;106(5):733-743. doi: 10.1002/ajb2.1279. Epub 2019 May 1.

PMID:
31042317
32.

Setting traps for NKG2A gives NK cell immunotherapy a fighting chance.

Cichocki F, Miller JS.

J Clin Invest. 2019 Apr 15;129(5):1839-1841. doi: 10.1172/JCI128480. eCollection 2019 Apr 15.

33.

Auditory evoked response delays in children with 47,XYY syndrome.

Bloy L, Ku M, Edgar JC, Miller JS, Blaskey L, Ross J, Roberts TPL.

Neuroreport. 2019 May 1;30(7):504-509. doi: 10.1097/WNR.0000000000001233.

PMID:
30896674
34.

A novel ex vivo tumor system identifies Src-mediated invasion and metastasis in mesenchymal tumor cells in non-small cell lung cancer.

Padhye A, Ungewiss C, Fradette JJ, Rodriguez BL, Albritton JL, Miller JS, Gibbons DL.

Sci Rep. 2019 Mar 20;9(1):4819. doi: 10.1038/s41598-019-41301-2.

35.

Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL.

Felices M, Kodal B, Hinderlie P, Kaminski MF, Cooley S, Weisdorf DJ, Vallera DA, Miller JS, Bachanova V.

Blood Adv. 2019 Mar 26;3(6):897-907. doi: 10.1182/bloodadvances.2018029371.

36.

An Observational Study With the Janssen Autism Knowledge Engine (JAKE®) in Individuals With Autism Spectrum Disorder.

Ness SL, Bangerter A, Manyakov NV, Lewin D, Boice M, Skalkin A, Jagannatha S, Chatterjee M, Dawson G, Goodwin MS, Hendren R, Leventhal B, Shic F, Frazier JA, Janvier Y, King BH, Miller JS, Smith CJ, Tobe RH, Pandina G.

Front Neurosci. 2019 Feb 27;13:111. doi: 10.3389/fnins.2019.00111. eCollection 2019.

37.

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab.

Erbe AK, Wang W, Carmichael L, Hoefges A, Grzywacz B, Reville PK, Ranheim EA, Hank JA, Kim K, Seo S, Mendonca EA, Song Y, Kenkre VP, Hong F, Gascoyne RD, Paietta E, Horning SJ, Miller JS, Kahl B, Sondel PM.

J Immunother Cancer. 2019 Mar 12;7(1):70. doi: 10.1186/s40425-019-0538-8.

38.

Predicted Risk of Mortality Score predicts 30-day readmission after coronary artery bypass grafting.

Rosenblum JM, Lovasik BP, Hunting JC, Binongo J, Halkos ME, Leshnower BG, Miller JS, Lattouf OM, Guyton RA, Keeling WB.

Gen Thorac Cardiovasc Surg. 2019 Aug;67(8):661-668. doi: 10.1007/s11748-019-01079-6. Epub 2019 Feb 8.

PMID:
30734216
39.

Direct observation of the intermediate in an ultrafast isomerization.

Porter TM, Wang J, Li Y, Xiang B, Salsman C, Miller JS, Xiong W, Kubiak CP.

Chem Sci. 2018 Oct 8;10(1):113-117. doi: 10.1039/c8sc03258k. eCollection 2019 Jan 7.

40.

Sperm maturation and male tactic-specific differences in ejaculates in the plainfin midshipman fish Porichthys notatus.

Miller JS, Bose APH, Fitzpatrick JL, Balshine S.

J Fish Biol. 2019 Mar;94(3):434-445. doi: 10.1111/jfb.13912. Epub 2019 Feb 21.

PMID:
30701548
41.

Adaptive NK cell reconstitution is associated with better clinical outcomes.

Cichocki F, Taras E, Chiuppesi F, Wagner JE, Blazar BR, Brunstein C, Luo X, Diamond DJ, Cooley S, Weisdorf DJ, Miller JS.

JCI Insight. 2019 Jan 24;4(2). pii: 125553. doi: 10.1172/jci.insight.125553. [Epub ahead of print]

42.

Assessing Canonical and Adaptive Natural Killer Cell Function in Suppression Assays In Vitro.

Sarhan D, Miller JS.

Methods Mol Biol. 2019;1913:153-166. doi: 10.1007/978-1-4939-8979-9_11.

PMID:
30666605
43.

Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.

Uppendahl LD, Felices M, Bendzick L, Ryan C, Kodal B, Hinderlie P, Boylan KLM, Skubitz APN, Miller JS, Geller MA.

Gynecol Oncol. 2019 Apr;153(1):149-157. doi: 10.1016/j.ygyno.2019.01.006. Epub 2019 Jan 15.

44.

Monocyte Subpopulation Recovery as Predictors of Hematopoietic Cell Transplantation Outcomes.

Turcotte LM, Cao Q, Cooley SA, Curtsinger J, Holtan SG, Luo X, Yingst A, Weisdorf DJ, Blazar BR, Miller JS, Wagner JE, Verneris MR.

Biol Blood Marrow Transplant. 2019 May;25(5):883-890. doi: 10.1016/j.bbmt.2019.01.003. Epub 2019 Jan 6.

PMID:
30625388
45.

Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.

Bachanova V, Weisdorf DJ, Wang T, Marsh SGE, Cereb N, Haagenson MD, Spellman SR, Lee SJ, Guethlein LA, Parham P, Miller JS, Cooley SA.

Biol Blood Marrow Transplant. 2019 May;25(5):949-954. doi: 10.1016/j.bbmt.2018.12.763. Epub 2018 Dec 27.

PMID:
30594542
46.

Early Indicators of Creatine Transporter Deficiency.

Miller JS, Thomas RP, Bennett A, Bianconi S, Bruchey A, Davis RJ, Ficicioglu C, Guthrie W, Porter FD, Thurm A.

J Pediatr. 2019 Mar;206:283-285. doi: 10.1016/j.jpeds.2018.11.008. Epub 2018 Dec 20.

47.

Anomalous Stoichiometry, 3-D Bridged Triangular/Pentagonal Layered Structured Artificial Antiferromagnet for the Prussian Blue Analogue A3MnII5(CN)13 (A = NMe4, NEtMe3). A Cation Adaptive Structure.

Lapidus SH, Graham AG, Kareis CM, Hawkins CG, Stephens PW, Miller JS.

J Am Chem Soc. 2019 Jan 16;141(2):911-921. doi: 10.1021/jacs.8b10638. Epub 2019 Jan 4.

PMID:
30557002
48.

Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control.

Grzywacz B, Moench L, McKenna D Jr, Tessier KM, Bachanova V, Cooley S, Miller JS, Courville EL.

J Immunother. 2019 Feb/Mar;42(2):65-72. doi: 10.1097/CJI.0000000000000250.

49.

Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients.

Hoogstad-van Evert JS, Maas RJ, van der Meer J, Cany J, van der Steen S, Jansen JH, Miller JS, Bekkers R, Hobo W, Massuger L, Dolstra H.

Oncotarget. 2018 Oct 5;9(78):34810-34820. doi: 10.18632/oncotarget.26199. eCollection 2018 Oct 5.

50.

Anomalous Stoichiometry and Antiferromagnetic Ordering for the Extended Hydroxymanganese(II) Cubes/Hexacyanometalate-Based 3D-Structured [MnII 4 (OH)4 ][MnII (CN)6 ](OH2 )6 ⋅H2 O.

Lapidus SH, Stephens PW, Kareis CM, VanNatta PE, Miller JS.

Chemistry. 2019 Feb 1;25(7):1752-1757. doi: 10.1002/chem.201804935. Epub 2019 Jan 8.

PMID:
30286266

Supplemental Content

Loading ...
Support Center